ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,076Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 890

$894K Total Retail Price of All Prescriptions

Rank: 69 out of 890

534 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 15,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 661 553 1 4
LEVOTHYROXINE SODIUM 579 521 2 2
OMEPRAZOLE 479 410 3 8
FUROSEMIDE 467 448 4 7
AMLODIPINE BESYLATE 451 390 5 1
SERTRALINE HCL 437 397 6 26
SIMVASTATIN 406 343 7 5
HYDROCODONE-ACETAMINOPHEN 382 371 S3 8 3
GLIMEPIRIDE 363 311 9 27
DOXYCYCLINE HYCLATE 357 280 10 89
METOPROLOL TARTRATE 320 272 11 15
METFORMIN HCL 313 256 12 6
TRAMADOL HCL 287 237 13 16
ATORVASTATIN CALCIUM 234 175 14 13
ZOLPIDEM TARTRATE 234 206 14 19
HYDROCHLOROTHIAZIDE 233 179 16 9
PREDNISONE 232 189 17 47
WARFARIN SODIUM 218 181 18 24
POTASSIUM CHLORIDE 215 180 19 11
METOPROLOL SUCCINATE 213 179 20 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 196 142 21 21
ALLOPURINOL 192 157 22 31
LOSARTAN POTASSIUM 183 140 23 29
CITALOPRAM HBR 174 132 24 20
LANTUS 172 137 25 50
TAMSULOSIN HCL 171 145 26 32
PRAVASTATIN SODIUM 169 146 27 10
CYMBALTA 160 140 28 45
LOVASTATIN 155 112 29 46
AMITRIPTYLINE HCL 153 117 R 30 43
NEXIUM 151 90 31 14
GABAPENTIN 134 102 32 12
CRESTOR 133 133 33 25
CLOPIDOGREL 132 109 34 28
NIFEDIPINE ER 129 113 35 75
BISOPROLOL FUMARATE 126 105 36 163
DONEPEZIL HCL 121 121 37 30
ATENOLOL 118 104 38 23
ADVAIR DISKUS 117 109 39 52
LOSARTAN-HYDROCHLOROTHIAZIDE 113 78 40 57
INSULIN SYRINGE 113 93 40 99
RANITIDINE HCL 111 99 42 49
METHYLPREDNISOLONE 110 98 43 109
PLAVIX 109 86 44 42
RISPERIDONE 108 95 45 78
NOVOLIN 70-30 107 81 46 199
LEVOFLOXACIN 104 85 47 107
DIGOXIN 101 101 48 65
ALENDRONATE SODIUM 100 100 49 38
KLOR-CON M10 100 93 49 165
CARVEDILOL 100 78 49 22
PREMARIN 98 51 R 52 105
MELOXICAM 97 78 53 18
PAROXETINE HCL 97 68 53 68
FINASTERIDE 97 97 53 108
ISOSORBIDE MONONITRATE ER 97 97 53 60
LYRICA 95 62 57 71
NAMENDA 93 93 58 36
CIPROFLOXACIN HCL 85 75 59 58
NOVOLIN R 83 78 60 153
MECLIZINE HCL 82 72 61 97
ESCITALOPRAM OXALATE 79 75 62 51
CYCLOBENZAPRINE HCL 78 53 R 63 64
PHENYTOIN SODIUM EXTENDED 75 51 64 111
ENALAPRIL MALEATE 75 63 64 56
CLONIDINE HCL 73 63 66 35
KLOR-CON M20 73 68 66 72
LIPITOR 71 70 68 77
FAMOTIDINE 70 64 69 90
SPIRONOLACTONE 67 55 70 85
JANUVIA 65 59 71 59
MUPIROCIN 64 52 72 121
DILTIAZEM 24HR CD 64 64 72 156
PROPRANOLOL HCL 64 49 72 141
DIOVAN 63 47 75 33
LOVAZA 59 54 76 120
AZITHROMYCIN 59 43 76 37
QUETIAPINE FUMARATE 58 26 78 73
FLUTICASONE PROPIONATE 58 51 78 39
TRAZODONE HCL 57 40 80 40
CHLORTHALIDONE 56 53 81 204
SPIRIVA 56 56 81 66
NYSTATIN 55 41 83 173
CELEBREX 55 51 83 91
PRIMIDONE 54 54 85 289
MEGESTROL ACETATE 53 44 R 86 92
PANTOPRAZOLE SODIUM 52 33 87 34
FLUOXETINE HCL 52 40 87 63
LABETALOL HCL 52 49 87 208
DILTIAZEM 24HR ER 51 51 90 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.